Related Articles
Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk
Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
Association between manganese superoxide dismutase gene polymorphism and breast cancer risk: A meta-analysis of 17,842 subjects
Breast cancer risk and polymorphisms in genes involved in metabolism of estrogens (CYP17, HSD17β1, COMT and MnSOD): Possible protective role of MnSOD gene polymorphism Val/Ala and Ala/Ala in women that never breast fed